retatrutide type 2 diabetes phase 2 trial is investigational and is not FDA approved. In TRANSCEND-T2D-1, investigators randomized 537 adults with inadequately controlled by diet and exercise in a 40-week, double-blind, placebo-controlled 3 The numbers from Lilly's Phase

Moreno-Perez O, Reyes-Garcia R, Modrego-Pardo I, Lopez-Martinez M, Soler MJ

All applicable regulations regarding the purchase and use of research peptides in your jurisdiction must be observed

Also known as insulin resistance syndrome, metabolic syndrome is defined as a group of conditions that together raise the risk of heart disease, diabetes, stroke, and other serious health issues

This monitoring typically includes follow-up appointments where healthcare providers assess weight changes, metabolic markers, and any side effects experienced

Most of the time, you may not need to stop GLP-1 medication fully before surgery

According to a KFF analysis, as of November 2025, Rhode Island was one of only 13 states to cover GLP-1s for obesity through Medicaid